Fluvoxamine Maleate Tablet, Film Coated
Product Images NDC 0832-1671
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fluvoxamine Maleate (NDC 0832-1671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (25 mg Tablet Bottle Label)
Each tablet contains 25mg of luvoxamine maleate, a medication used for the treatment of depression, obsessive-compulsive disorder, and anxiety disorders. The usual dosage should be in accordance with the prescribing information guidelines. It comes in a child-resistant package and should be stored at 20°C to 25°C (68°F to 77°F). The package is light-resistant and humidity should be avoided, so it should be protected from light and kept out of reach of children. The package contains 100 tablets and is only available with a prescription. The address of the manufacturer is in Maple Grove, Minnesota, and there is another address in Tucson, Arizona.*
Principal Display Panel (50 mg Tablet Bottle Label)
Fluvoxamine Maleate is a medication available in tablet form with a strength of 50mg. The recommended dosage information can be found in the prescribing information. It comes in a child-resistant package and should be stored at controlled room temperature, protected from light and high humidity. The medication should be kept out of reach of children. Upsher-Smith Laboratories manufactures the medication.*
Principal Display Panel (100 mg Tablet Bottle Label)
Fluvoxamine Maleate is a type of medication which comes in tablet form. Each tablet includes 100 mg of luvoxamine maleate, USP, and the recommended dosage should be determined by the prescribing physician. The package should be stored in a cool, dry place between 20-25°C and should be protected from light and high humidity. It is important for pharmacists to provide a tight and light-resistant container to patients as defined in the USP with a child-resistant closure. This medication should be kept out of the reach of children. Upsher-Smith Laboratories manufactured this product, and ©2021 Upsher-Smith Laboratories, LLC owns the rights to it. Note: Some of the letters in the text are not clear.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.